BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 34620874)

  • 1. Histiocytic disorders.
    McClain KL; Bigenwald C; Collin M; Haroche J; Marsh RA; Merad M; Picarsic J; Ribeiro KB; Allen CE
    Nat Rev Dis Primers; 2021 Oct; 7(1):73. PubMed ID: 34620874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncommon histiocytic disorders: Rosai-Dorfman, juvenile xanthogranuloma, and Erdheim-Chester disease.
    Haroche J; Abla O
    Hematology Am Soc Hematol Educ Program; 2015; 2015():571-8. PubMed ID: 26637774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.
    Chakraborty R; Hampton OA; Shen X; Simko SJ; Shih A; Abhyankar H; Lim KP; Covington KR; Trevino L; Dewal N; Muzny DM; Doddapaneni H; Hu J; Wang L; Lupo PJ; Hicks MJ; Bonilla DL; Dwyer KC; Berres ML; Poulikakos PI; Merad M; McClain KL; Wheeler DA; Allen CE; Parsons DW
    Blood; 2014 Nov; 124(19):3007-15. PubMed ID: 25202140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of neuroimaging features of histiocytic neoplasms with central nervous system involvement: a retrospective study of 121 adult patients.
    Fan X; Liu T; Zhang Z; Sun J; Niu N; Mao C; Wang F; Li J; Zhou D; Cao X; Jin Z; Feng F
    Eur Radiol; 2023 Nov; 33(11):8031-8042. PubMed ID: 37191919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histiocytic Disorders of Childhood.
    Eckstein OS; Picarsic J; Allen CE
    Pediatr Rev; 2022 Oct; 43(10):561-571. PubMed ID: 36180546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological and clinical significance of somatic mutations in Langerhans cell histiocytosis and related histiocytic neoplastic disorders.
    Allen CE; Parsons DW
    Hematology Am Soc Hematol Educ Program; 2015; 2015():559-64. PubMed ID: 26637772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
    Papo M; Cohen-Aubart F; Trefond L; Bauvois A; Amoura Z; Emile JF; Haroche J
    Curr Oncol Rep; 2019 May; 21(7):62. PubMed ID: 31115724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological Manifestations of Histiocytic Disorders.
    Banks SA; Sartori Valinotti JC; Go RS; Abeykoon JP; Goyal G; Young JR; Koster MJ; Vassallo R; Ryu JH; Davidge-Pitts CJ; Ravindran A; Bennani NN; Shah MV; Rech KL; Tobin WO;
    Curr Neurol Neurosci Rep; 2023 Jun; 23(6):277-286. PubMed ID: 37209319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An overview of histiocytosis].
    Tojo A
    Rinsho Ketsueki; 2022; 63(5):363-367. PubMed ID: 35662158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.
    Simko SJ; Tran HD; Jones J; Bilgi M; Beaupin LK; Coulter D; Garrington T; McCavit TL; Moore C; Rivera-Ortegón F; Shaffer L; Stork L; Turcotte L; Welsh EC; Hicks MJ; McClain KL; Allen CE
    Pediatr Blood Cancer; 2014 Mar; 61(3):479-87. PubMed ID: 24106153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OCT2 expression in histiocytoses.
    Ungureanu IA; Cohen-Aubart F; Héritier S; Fraitag S; Charlotte F; Lequain H; Hélias-Rodzewicz Z; Haroche J; Donadieu J; Emile JF
    Virchows Arch; 2023 Jul; 483(1):81-86. PubMed ID: 36754897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults.
    Milne P; Bigley V; Bacon CM; Néel A; McGovern N; Bomken S; Haniffa M; Diamond EL; Durham BH; Visser J; Hunt D; Gunawardena H; Macheta M; McClain KL; Allen C; Abdel-Wahab O; Collin M
    Blood; 2017 Jul; 130(2):167-175. PubMed ID: 28512190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in the Histopathologic Diagnosis of Histiocytic Neoplasms.
    Rech KL; He R
    J Natl Compr Canc Netw; 2021 Nov; 19(11):1305-1311. PubMed ID: 34781270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Langerhans Cell Histiocytosis and Histiocytic Disorders: A Focus on MAPK Pathway Inhibitors.
    Geerlinks AV; Abla O
    Paediatr Drugs; 2023 Jul; 25(4):399-409. PubMed ID: 37204611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Musculoskeletal imaging features of non-Langerhans cell histiocytoses.
    Choraria A; Andrei V; Rajakulasingam R; Saifuddin A
    Skeletal Radiol; 2021 Oct; 50(10):1921-1940. PubMed ID: 33787962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease.
    Picarsic J; Pysher T; Zhou H; Fluchel M; Pettit T; Whitehead M; Surrey LF; Harding B; Goldstein G; Fellig Y; Weintraub M; Mobley BC; Sharples PM; Sulis ML; Diamond EL; Jaffe R; Shekdar K; Santi M
    Acta Neuropathol Commun; 2019 Nov; 7(1):168. PubMed ID: 31685033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histiocytosis and the nervous system: from diagnosis to targeted therapies.
    Cohen Aubart F; Idbaih A; Emile JF; Amoura Z; Abdel-Wahab O; Durham BH; Haroche J; Diamond EL
    Neuro Oncol; 2021 Sep; 23(9):1433-1446. PubMed ID: 33993305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare diseases of bone: Erdheim-Chester and Rosai-Dorfman non-Langerhans cell histiocytoses.
    Mavrogenis AF; Igoumenou VG; Antoniadou T; Megaloikonomos PD; Agrogiannis G; Foukas P; Papageorgiou SG
    EFORT Open Rev; 2018 Jun; 3(6):381-390. PubMed ID: 30034819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highlights of the Management of Adult Histiocytic Disorders: Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Rosai-Dorfman Disease, and Hemophagocytic Lymphohistiocytosis.
    Salama HA; Jazieh AR; Alhejazi AY; Absi A; Alshieban S; Alzahrani M; Alaskar A; Gmati G; Damlaj M; Abuelgasim KA; Alghamdi A; Alahmari B; Almugairi A; Alzahrani H; Bazarbachi A; Musa MOH; Goyal G
    Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e66-e75. PubMed ID: 32943371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ophthalmologic Involvement in Adults with Histiocytic Disorders: Clinical Presentation and Treatment Outcomes.
    Banks SA; Bhatti MT; Go RS; Abeykoon JP; Acosta-Medina AA; Hazim AZ; Goyal G; Young JR; Koster MJ; Vassallo R; Ryu JH; Davidge-Pitts CJ; Ravindran A; Sartori Valinotti JC; Bennani NN; Shah MV; Rech KL; Garrity JA; Tobin WO;
    Ophthalmology; 2023 Jan; 130(1):77-86. PubMed ID: 35932838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.